Leerink Partners Reiterates Outperform Rating on Tenaya Therapeutics Inc (TNYA): "remains on track to share interim data"
Tweet Send to a Friend
Leerink Partners analyst Mani Foroohar reiterated an Outperform rating and $2.00 price target on Tenaya Therapeutics Inc (NASDAQ: TNYA)The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
